Intuitive Surgical management check

ISRG · Health Care · Health Care Equipment · CEO David J. Rosa / Gary S. Guthart, Ph.D.

Filings as of

72
Management score, ranked 153rd of 487 · 16th of 60 in Health Care4 good · 3 to watch · 0 flaggedStrongest: owner returns · Weakest: stable leadership · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$287Peers$103

    What $100 became since fiscal 2021

    100100th
    Detail

    $100 invested at the start of fiscal 2021 grew to $287, against $103 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    9068th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.80 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.7% of net income

    $21.0m pay · $2.9bn net income, FY2025

    0.1%1%3%10%
    6161st
    Detail

    $21.0m of reported pay in fiscal 2025, against $2.9bn of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 4.9 years of pay

    247,803 shares ≈ $102.0m

    0.1y1y5y20y100y

    6 mo: ▲ $0 bought · ▼ $27.3m sold

    6973rd
    Detail

    The CEO holds 247,803 shares, directly or through trusts (unvested awards not counted): about 4.9 years of pay. Light activity: no buys, $27.3m sold in six months. 45 of 45 sales ran on pre-arranged 10b5-1 plans.

  • Watch

    Are owners being diluted?

    Share count growing2021 · 366m2025 · 363m

    Diluted shares +0.7% a year; flagged above +2%

    0%10%20%

    Stock pay 7.8% of revenue

    4121st
    Detail

    Diluted shares changed +0.7% a year over the last three fiscal years. Stock-based pay was 7.8% of revenue in the latest year.

  • Watch

    Is leadership stable?

    2 CEOs in the pay table

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Gary S. Guthart, Ph.D., David J. Rosa / Gary S. Guthart, Ph.D.

    4018th
    Detail

    CEOs in the pay table: Gary S. Guthart, Ph.D., David J. Rosa / Gary S. Guthart, Ph.D.. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 13, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$21.3m$42.6m$10020212022202320242025$287$103

Pay tied most to (3)AOI

Other key measuresAOIRelative TSRDa Vinci and Ion procedure growth

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025David J. Rosa / Gary S. Guthart, Ph.D.$21.0m$26.4m$6.4m$287$103$2.9bn
2024Gary S. Guthart, Ph.D.$18.2m$42.6m$8.4m$265$104$2.3bn
2023Gary S. Guthart, Ph.D.$12.4m$22.7m$6.9m$171$99$1.8bn
2022Gary S. Guthart, Ph.D.$10.3m$1.6m$5.0m$135$105$1.3bn
2021Gary S. Guthart, Ph.D.$8.1m$17.5m$4.5m$182$137$1.7bn

Insiders and the CEO's stakeQuiet

Chief Executive Officer (CEO)
David J. Rosa
Shares held
247,803
At that filing's price
≈ $102.0m
Latest Form 4
Jul 10, 2026

Light activity: no buys, $27.3m sold in six months. 45 of 45 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldGary S GuthartDirector · 10b5-1 plan$17.6mNov 4, 2026
  • SoldFredrik WidmanVP Corporate Controller · 10b5-1 plan$4.6mOct 30, 2026
  • SoldIman JeddiSVP & GM da Vinci Platforms & · 10b5-1 plan$2.4mJun 1, 2026
  • SoldCraig H BarrattDirector · 10b5-1 plan$1.0mNov 4, 2026

Leadership and governance on file

20222023202420252026Leadership 12Votes 5
All 12 filings

Latest shareholder vote results: May 4, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $5.3bn returned to owners in buybacks and dividends, 53% of net income, and $3.0bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$1.4bn$2.9bn20212022202320242025Shares366m362m357m362m363m
Show the figures
Fiscal year20212022202320242025
Revenue$5.7bn$6.2bn$7.1bn$8.4bn$10.1bn
Net income$1.7bn$1.3bn$1.8bn$2.3bn$2.9bn
Stock-based pay$449.2m$513.2m$592.8m$676.8m$788.2m
Buybacks$0$2.6bn$416.3m$0$2.3bn
Dividends—————
Diluted shares366m362m357m362m363m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.